The management of peritoneal and hepatic metastases from gastrointestinal s
tromal tumors is a challenging clinical problem. Currently available system
ic therapeutic agents have very limited activity in this particular disease
. Patients with disease confined to a single organ/region are therefore man
aged either by surgery or regional therapy e.g. intraperitoneal therapy or
hepatic arterial chemoembolization, whereas those with multiple sites of in
volvement should be enrolled on experimental trials of new agents. (C) 2000
Elsevier Science Ltd. All rights reserved.